Page last updated: 2024-11-07

4-amino-3-hydroxybenzoic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID137566
CHEMBL ID1462
SCHEMBL ID180385
MeSH IDM0472195

Synonyms (43)

Synonym
AC-4479
EN300-42793
nsc 407243
4a3 ,
nsc407243
nsc-407243
2374-03-0
4-amino-3-hydroxybenzoic acid ,
benzoic acid, 4-amino-3-hydroxy-
inchi=1/c7h7no3/c8-5-2-1-4(7(10)11)3-6(5)9/h1-3,9h,8h2,(h,10,11
2HDR ,
4-amino-3-hydroxybenzoic acid, 97%
A1194
KUC106686N
ksc-11-207-17
CHEMBL1462 ,
AKOS005255334
bdbm50324681
A816876
3-hydroxy-p-aminobenzoic acid
(4-carboxy-2-hydroxyphenyl)amine
3-hydroxy-4-aminobenzoic acid
GEO-00141
4-amino-3-hydroxy benzoic acid
FT-0617496
PS-4562
AM20060231
3-hydroxy 4-amino benzoic acid
SCHEMBL180385
mfcd00017094
SY018797
Q-200427
STR04495
DTXSID90178409
CS-W002114
oxybuprocaine hydrochloride imp. c (ep); oxybuprocaine imp. c (ep); 4-amino-3-hydroxybenzoic acid; oxybuprocaine hydrochloride impurity c; oxybuprocaine impurity c
4-amino-3-hydroxybenzoicacid
Q27454543
tafamidis intermediate
HY-W002114
Z431554234
3-hydroxy-paba
DCB6PQR8WG
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (5)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, Beta-lactamaseEscherichia coli K-12Ki19,000.000019,000.000029,500.000040,000.0000AID977610
Chain A, Beta-lactamaseEscherichia coli K-12Ki19,000.000019,000.000029,500.000040,000.0000AID977610
Chain A, Beta-lactamaseEscherichia coli K-12Ki19,000.00005.000019,668.333340,000.0000AID977610
Chain A, Beta-lactamaseEscherichia coli K-12Ki19,000.000019,000.000029,500.000040,000.0000AID977610
Beta-lactamaseEscherichia coli K-12Ki19,000.00000.02703.64137.3000AID500280
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (2)

Processvia Protein(s)Taxonomy
antibiotic catabolic processBeta-lactamaseEscherichia coli K-12
response to antibioticBeta-lactamaseEscherichia coli K-12
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (2)

Processvia Protein(s)Taxonomy
beta-lactamase activityBeta-lactamaseEscherichia coli K-12
hydrolase activityBeta-lactamaseEscherichia coli K-12
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (2)

Processvia Protein(s)Taxonomy
outer membrane-bounded periplasmic spaceBeta-lactamaseEscherichia coli K-12
periplasmic spaceBeta-lactamaseEscherichia coli K-12
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (10)

Assay IDTitleYearJournalArticle
AID977610Experimentally measured binding affinity data (Ki) for protein-ligand complexes derived from PDB2006Nature chemical biology, Dec, Volume: 2, Issue:12
Deconstructing fragment-based inhibitor discovery.
AID1811Experimentally measured binding affinity data derived from PDB2006Nature chemical biology, Dec, Volume: 2, Issue:12
Deconstructing fragment-based inhibitor discovery.
AID714147Activity of Trametes versicolor laccase by spectrophotometric analysis2012Bioorganic & medicinal chemistry, Mar-01, Volume: 20, Issue:5
Redox potentials, laccase oxidation, and antilarval activities of substituted phenols.
AID714148Inhibition of Trametes versicolor laccase2012Bioorganic & medicinal chemistry, Mar-01, Volume: 20, Issue:5
Redox potentials, laccase oxidation, and antilarval activities of substituted phenols.
AID1146778Antimicrobial activity against Escherichia coli assessed as growth inhibition after 24 hrs by turbidimetric analysis1977Journal of medicinal chemistry, Mar, Volume: 20, Issue:3
P-Aminobenzoic acid derivatives. Mode of action and structure-activity relationships in a cell-free system (Escherichia coli).
AID500280Inhibition of Escherichia coli AmpC assessed as nitrocefin hydrolysis by UV-Vis spectrophotometry2006Nature chemical biology, Dec, Volume: 2, Issue:12
Deconstructing fragment-based inhibitor discovery.
AID714146Ratio of kcat to Km for Trametes versicolor laccase2012Bioorganic & medicinal chemistry, Mar-01, Volume: 20, Issue:5
Redox potentials, laccase oxidation, and antilarval activities of substituted phenols.
AID1146779Dissociation constant, pKa of the compound by spectrophotometric analysis1977Journal of medicinal chemistry, Mar, Volume: 20, Issue:3
P-Aminobenzoic acid derivatives. Mode of action and structure-activity relationships in a cell-free system (Escherichia coli).
AID293934Inhibition of pieris rapae Phenoloxidase2007Bioorganic & medicinal chemistry, Mar-01, Volume: 15, Issue:5
3D-QSAR and molecular docking studies of benzaldehyde thiosemicarbazone, benzaldehyde, benzoic acid, and their derivatives as phenoloxidase inhibitors.
AID1146775Binding affinity to human serum albumin at 100 umol/l by equilibrium dialysis technique1977Journal of medicinal chemistry, Mar, Volume: 20, Issue:3
P-Aminobenzoic acid derivatives. Mode of action and structure-activity relationships in a cell-free system (Escherichia coli).
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (8)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (12.50)18.7374
1990's0 (0.00)18.2507
2000's4 (50.00)29.6817
2010's2 (25.00)24.3611
2020's1 (12.50)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 28.67

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index28.67 (24.57)
Research Supply Index2.20 (2.92)
Research Growth Index4.37 (4.65)
Search Engine Demand Index32.99 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (28.67)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other8 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]